HIMS250502C31000
- 10.00
- 0.000.00%
Hims & Hers Health Newsroom
Hims & Hers Joins Nvidia, Tesla, Apple in Most Active Stock Options: Options Chatter
Hims & Hers Stock Gains 15%+ After Earnings Even Though the Sales Outlook Looks Low
Hims & Hers Health, Inc. Reports Strong Q1 Earnings
Hims & Hers Health Options Spot-On: On May 6th, 697.94K Contracts Were Traded, With 749.91K Open Interest
Hims & Hers Health Up Over 17%, on Track for Longest Winning Streak Since February -- Data Talk
Hims & Hers Health Has a Range of Strategies It Can Pursue -- Market Talk
Tesla, Palantir, Hims & Hers, Ford, DoorDash, SolarEdge, Vertex: Biggest Movers
Trending Stocks Today | FOXO Technologies Surges 148.38%
10 Health Care Stocks With Whale Alerts In Today's Session
Is Hims & Hers Health Stock (HIMS) the Target of a Meme-Driven Short Squeeze?
Express News | Citigroup Maintains Sell on Hims & Hers Health, Raises Price Target to $30
What's Going On With Hims & Hers Stock Tuesday?
U.S. stocks are moving differently | Q1 performance exceeded expectations, Hims & Hers Health (HIMS.US) surged over 10%.
On Tuesday, Hims & Hers Health (HIMS.US) surged over 10%, reaching $46.46.
Looking At Hims & Hers Health's Recent Unusual Options Activity
Hims & Hers Health Faces Strategic Choice Between Semaglutide Expansion or Core Business, BofA Says
FARO Technologies, Celanese, Avient, Aramark And Other Big Stocks Moving Higher On Tuesday
HIMS Stock Has Given up Its Prior Loss. Hims & Hers Health Shares Were Trading Lower After the Company Reported Q1 Financial Results. Also, the Company Issued Q2 Revenue Guidance Below Estimates.
Daily short sale tracking: Skechers USA's short volume increased by 11 million, with a short sale ratio of 15%
New Analyst Forecast: $HIMS Given 'Neutral' Rating
Today's Pre-Market Movers and Top Ratings | PLTR, HIMS, TSLA and More